Professor Peter Taylor
Professor Taylor studied pre-clinical medical sciences at Gonville and Caius College at the University of Cambridge, United Kingdom, and Clinical Medicine at the University of Oxford. He was awarded a PhD degree from the University of London, UK for studies on the pathogenesis of arthritis.
In the summer of 2015, he was appointed as Medical Director of the National Rheumatoid Arthritis Society, an outstanding patient-led charity.
Professor Taylor chairs the UK government’s National Institute for Health Research and Translational Research Collaboration in Rheumatology, which brings together the UK’s leading academic and clinical centers for translational research in a partnership of universities and National Health Service hospitals. He was a Distinguished Member of the British Society for Rheumatology in 2016.
Professor Taylor has specialist clinical interests in inflammatory arthritis with over 20 years of experience in clinical trial design. He undertakes international leadership in studies of biological and small molecular therapies in inflammatory arthritis including the earliest seminal trails of anti-TNF and anti-IL-6 receptor therapy (drugs for arthritis).
His research expertise is in clinical trials of novel therapies targeting pathogenesis to investigate the in vivo role of the target.
